U-PGx Test
One Test for Life, for 76 Index Drugs
Genotyping by PCR
Turnaround Time: 7 days
Brochure for Clinics: Download
U-PGx Test by Acumen Diagnostics Lab
1 Test:
12 Genes
76 Index Drugs
11,000 Medications
Clinical Utility
CYP2C19 is a cytochrome P450 required in the biotransformation of drugs into active or inactive metabolites.
Common genetic variations in CYP2C19 lead to increased or reduced enzymatic function. Prescribing wrong drug doses can thus cause adverse reactions.
Pharmacogenomics (PGx) genotyping of CYP2C19 provides medical insights for drug use.
Common Genotyping Results and
CPIC® Therapeutic Recommendations
Note: All phenotype information extracted from CPIC® guidelines. Therapeutic recommendations from: Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.
^ Interpretive drug information is only available for certain genetic results.
Medication Insights information are extracted from CPIC® guidelines.
Result Report
In-a-glance reporting of genotyping result with reported clinical consequences according to studies and published guidelines from the CPIC®.
Download examples of Result Report.
^Medical Insights and Therapeutic Recommendation information are extracted from CPIC® guidelines.